Top Markets
#1 B3 (Base) B3 (Base) +14.17%
#2 Janction Janction +12.47%
#3 DMT-NAT DMT-NAT +11.90%
#4 Fake World Assets Fake World Assets +11.22%
#5 TENDIES TENDIES +6.21%
#6 Status Status +4.85%
#7 GoPlus Security GoPlus Security +4.76%
#8 龙虾 (Lobster) 龙虾 (Lobster) +4.30%
#9 Provenance Blockchain Provenance Blockchain +3.88%
#10 Everything Everything +3.72%
Coin of the day
B3 (Base) B3 (Base)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Ultimovacs ASA Ultimovacs ASA

Ultimovacs ASA

ULTI
Rang in aandelen #34179
Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established... Ultimovacs ASA is a pharmaceutical company based in Oslo, Norway, established in 2011. The firm specializes in developing immunotherapies to combat various cancers. Its main product in development is UV1, a peptide vaccine engineered to stimulate a T-cell immune response against telomerase, an antigen found widely across different cancer types.
Aandeelprijs
$0.17687105
Laatst gesynchroniseerd: 2025-04-01
Marktkapitalisatie
$6.08M
Verandering (1 dag)
-89.96%
Verandering (1 jaar)
0.00%
Land
NO
Handel Ultimovacs ASA (ULTI)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Ultimovacs ASA (ULTI)
Het dividendrendement (TTM) van Ultimovacs ASA (aandelsymbool: ULTI) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Ultimovacs ASA (ULTI) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE